Kalaycio M[au] - Search Results

Year	Number of Results
1997	3
1998	7
1999	2
2000	5
2001	5
2002	6
2003	6
2004	8
2005	8
2006	14
2007	12
2008	10
2009	15
2010	20
2011	25
2012	15
2013	18
2014	23
2015	20
2016	21
2017	16
2018	14
2019	21
2020	14
2021	7
2022	3

1

Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic Review.

Warraich Z, Tenneti P, Thai T, Hubben A, Amin H, McBride A, Warraich S, Hannan A, Warraich F, Majhail N, Kalaycio M, Anwer F. Warraich Z, et al. Among authors: kalaycio m. Biol Blood Marrow Transplant. 2020 Mar;26(3):e55-e64. doi: 10.1016/j.bbmt.2019.09.022. Epub 2019 Sep 23. Biol Blood Marrow Transplant. 2020. PMID: 31557532 Free article. Review.

2

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W. Armand P, et al. Among authors: kalaycio me. Blood. 2014 Jun 5;123(23):3664-71. doi: 10.1182/blood-2014-01-552984. Epub 2014 Apr 17. Blood. 2014. PMID: 24744269 Free PMC article.

3

Prolymphocytic leukemia.

Absi A, Hsi E, Kalaycio M. Absi A, et al. Among authors: kalaycio m. Curr Treat Options Oncol. 2005 May;6(3):197-208. doi: 10.1007/s11864-005-0003-4. Curr Treat Options Oncol. 2005. PMID: 15869731 Review.

4

Monoclonal gammopathy of undetermined significance: A primary care guide.

Khouri J, Samaras C, Valent J, Mejia Garcia A, Faiman B, Mathur S, Hamilton K, Nakashima M, Kalaycio M. Khouri J, et al. Among authors: kalaycio m. Cleve Clin J Med. 2019 Jan;86(1):39-46. doi: 10.3949/ccjm.86a.17133. Cleve Clin J Med. 2019. PMID: 30624183 Free article. Review.

5

Leukemia in pregnancy.

Brell J, Kalaycio M. Brell J, et al. Among authors: kalaycio m. Semin Oncol. 2000 Dec;27(6):667-77. Semin Oncol. 2000. PMID: 11130474 Review.

6

Your patient has chronic leukemia: Now what?

Kalaycio M. Kalaycio M. Cleve Clin J Med. 2016 Aug;83(8):575-81. doi: 10.3949/ccjm.83gr.16002. Cleve Clin J Med. 2016. PMID: 27505878 Free article. Review.

7

Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?

Madanat YF, Kalaycio ME, Nazha A. Madanat YF, et al. Among authors: kalaycio me. Acta Med Acad. 2019 Apr;48(1):35-44. doi: 10.5644/ama2006-124.240. Acta Med Acad. 2019. PMID: 31264431 Free article. Review.

8

Accelerated Phase CML: Outcomes in Newly Diagnosed vs. Progression From Chronic Phase.

Mukherjee S, Kalaycio M. Mukherjee S, et al. Among authors: kalaycio m. Curr Hematol Malig Rep. 2016 Apr;11(2):86-93. doi: 10.1007/s11899-016-0304-7. Curr Hematol Malig Rep. 2016. PMID: 26932346 Review.

9

Fludarabine: a review of the clear benefits and potential harms.

Lukenbill J, Kalaycio M. Lukenbill J, et al. Among authors: kalaycio m. Leuk Res. 2013 Sep;37(9):986-94. doi: 10.1016/j.leukres.2013.05.004. Epub 2013 Jun 17. Leuk Res. 2013. PMID: 23787174 Review.

10

Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia.

Hill BT, Kalaycio M. Hill BT, et al. Among authors: kalaycio m. Onco Targets Ther. 2015 Aug 31;8:2391-7. doi: 10.2147/OTT.S68770. eCollection 2015. Onco Targets Ther. 2015. PMID: 26366093 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results